May 7, 2021
Via: CNBCPfizer and partner BioNTech said they have started the process of seeking full approval for their Covid vaccine for use in people 16 and older in the U.S., making the companies the first in the nation to file for full […]
FDA, Industry, News, Pricing, Regulations, Vaccines
May 7, 2021
Via: PMLiVEThe Biden-Harris Administration is backing a proposal from the World Trade Organization (WTO), supported by South Africa and India, that would temporarily remove IP protections on COVID-19 vaccines. The move itself is surprising, given that historically the US has been […]
May 5, 2021
Via: FiercePharmaBucking the pharma industry on the closely watched issue of patent rights for COVID-19 vaccines, the Biden administration came out in favor of a proposal at the World Trade Organization to suspend intellectual property protections for pandemic shots. In a […]
FDA, Industry, Regulations, Vaccines
May 4, 2021
Via: CNBCPfizer said Tuesday it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at the end of this month. If the FDA signs off, the company will be able to market the shot directly […]
April 29, 2021
Via: World Pharma NewsModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity […]
April 28, 2021
Via: EPM MagazineWe are seeing incredible progress in the roll-out of Covid-19 vaccines. We are on track for all adults in the UK to have been offered the vaccine by July. Researchers and healthcare workers are rightfully being celebrated for all their […]
Biotech, Industry, News, Vaccines
April 26, 2021
Via: Medical NewsThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged in late 2019 in Wuhan, China, and has led to high morbidity and mortality worldwide, with newer, more infectious variants rapidly emerging and infecting more people in several countries. Thanks […]
April 15, 2021
Via: Biopharma DiveThe coronavirus pandemic has made winners out of previously unproven biotechs like Moderna and BioNTech, which each developed strongly successful vaccines in record time. But it’s also featured surprising setbacks for some of the world’s leading infectious disease companies, like […]
April 14, 2021
Via: EPM MagazineThe sheer speed of developing and gaining regulatory approval for effective vaccines against Covid-19 has been unprecedented. Transporting them rapidly and safely from manufacturing sites to vaccination centres and doctors’ surgeries across the world is possibly the biggest challenge the […]
FDA, Industry, Regulations, Vaccines
April 13, 2021
Via: EPM MagazineThe company’s vaccine, which is manufactured by its subsidiary Janssen, has been administered to over 6.8 million people in the US. The decision by the FDA and the CDC was made after reports of six cerebral venous sinus thrombosis (CVST) […]
April 6, 2021
Via: CNBCPresident Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]
Biotech, Industry, Manufacturing, News, Research and Development, Vaccines
April 5, 2021
Via: BioSpaceEmergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]
April 29, 2021
April 22, 2021
Copyright © 2021. All rights reserved
